
Keywords: clinical trial; cystic fibrosis; exocrine pancreatic insufficiency; pancreatic enzyme-replacement therapy; BMI; Body mass index; CF; Cystic fibrosis; CFA; Coefficient of fat absorption; CNA; Coefficient of nitrogen absorption; EPI; Exocrine pancreatic ins